FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1724049693> ?p ?o ?g. }

• W1724049693 endingPage "2060" @default.
• W1724049693 startingPage "2048" @default.
• W1724049693 abstract "Randomized trials report equivalent efficacy among various combinations of platinum-based regimens in advanced non-small cell lung cancer (NSCLC). Their relative effectiveness and comparability based on squamous versus nonsquamous histology is uncertain.The authors used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data to identify first-line chemotherapy agents administered to Medicare beneficiaries with stage IIIB or IV NSCLC diagnosed from 2000 to 2007. Overall survival was compared between patients who received the 3 most common regimens: carboplatin-paclitaxel, carboplatin-gemcitabine, and carboplatin-docetaxel. Stratified analyses distinguished between the outcomes of patients with squamous versus nonsquamous cell histology. Multivariable Cox proportional hazards models and propensity score analyses facilitated adjustment for imbalance in measurable patient characteristics.Of the 15,318 patients who received first-line chemotherapy, 43.1% received carboplatin-paclitaxel, 14.3% received carboplatin-gemcitabine, 8.5% received carboplatin-docetaxel, and 34.1% received other regimens. The median survival was 8.0 months (interquartile range [IQR], 3.5-17.4 months) for carboplatin-paclitaxel, 7.3 months (IQR, 3.4-15.2 months) for carboplatin-gemcitabine, and 7.5 months (IQR, 3.2-16.0 months) for carboplatin-docetaxel. Both multivariable and propensity score-adjusted Cox models demonstrated a slight inferiority associated with carboplatin-gemcitabine or carboplatin-docetaxel versus carboplatin-paclitaxel, with a hazard ratio of 1.10 (95% confidence interval, 1.04-1.15) and 1.09 (95% confidence interval, 1.02-1.16), respectively, in propensity score-stratified models. Among the subgroup of 2063 patients with squamous carcinoma, propensity score-stratified analyses had a higher risk of death (hazard ratio, 1.20; 95% confidence interval, 1.07-1.35) associated with carboplatin-gemcitabine versus carboplatin-paclitaxel.Carboplatin-paclitaxel was associated with slightly better survival compared with carboplatin-gemcitabine or carboplatin-docetaxel within the Medicare population with advanced NSCLC, and this was most pronounced for patients who had squamous cell histology." @default.
• W1724049693 created "2016-06-24" @default.
• W1724049693 creator A5006543842 @default.
• W1724049693 creator A5008812852 @default.
• W1724049693 creator A5025840041 @default.
• W1724049693 creator A5043176593 @default.
• W1724049693 creator A5053521833 @default.
• W1724049693 creator A5088893766 @default.
• W1724049693 date "2013-04-05" @default.
• W1724049693 modified "2023-10-01" @default.
• W1724049693 title "Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer" @default.
• W1724049693 cites W1842046266 @default.
• W1724049693 cites W1935885922 @default.
• W1724049693 cites W1966347188 @default.
• W1724049693 cites W1978267288 @default.
• W1724049693 cites W1994736171 @default.
• W1724049693 cites W2000445173 @default.
• W1724049693 cites W2009187570 @default.
• W1724049693 cites W2017103957 @default.
• W1724049693 cites W2018802677 @default.
• W1724049693 cites W2026635246 @default.
• W1724049693 cites W2037139573 @default.
• W1724049693 cites W2049674541 @default.
• W1724049693 cites W2050119069 @default.
• W1724049693 cites W2052806549 @default.
• W1724049693 cites W2076315677 @default.
• W1724049693 cites W2077980919 @default.
• W1724049693 cites W2089927136 @default.
• W1724049693 cites W2099725888 @default.
• W1724049693 cites W2104616343 @default.
• W1724049693 cites W2104945409 @default.
• W1724049693 cites W2107193361 @default.
• W1724049693 cites W2108326787 @default.
• W1724049693 cites W2109063316 @default.
• W1724049693 cites W2112621029 @default.
• W1724049693 cites W2113003672 @default.
• W1724049693 cites W2120462386 @default.
• W1724049693 cites W2121095198 @default.
• W1724049693 cites W2121690051 @default.
• W1724049693 cites W2125357549 @default.
• W1724049693 cites W2127405377 @default.
• W1724049693 cites W2129168200 @default.
• W1724049693 cites W2132139248 @default.
• W1724049693 cites W2139939379 @default.
• W1724049693 cites W2140411476 @default.
• W1724049693 cites W2150291618 @default.
• W1724049693 cites W2151986118 @default.
• W1724049693 cites W2156728903 @default.
• W1724049693 cites W2157358083 @default.
• W1724049693 cites W2160131381 @default.
• W1724049693 cites W2161330753 @default.
• W1724049693 cites W2164067249 @default.
• W1724049693 cites W2166399931 @default.
• W1724049693 cites W2168639902 @default.
• W1724049693 cites W2607182122 @default.
• W1724049693 cites W2626223149 @default.
• W1724049693 cites W4239180165 @default.
• W1724049693 cites W4239728164 @default.
• W1724049693 cites W4248559216 @default.
• W1724049693 cites W4250849363 @default.
• W1724049693 doi "https://doi.org/10.1002/cncr.28022" @default.
• W1724049693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23564469" @default.
• W1724049693 hasPublicationYear "2013" @default.
• W1724049693 type Work @default.
• W1724049693 sameAs 1724049693 @default.
• W1724049693 citedByCount "15" @default.
• W1724049693 countsByYear W17240496932014 @default.
• W1724049693 countsByYear W17240496932015 @default.
• W1724049693 countsByYear W17240496932016 @default.
• W1724049693 countsByYear W17240496932017 @default.
• W1724049693 crossrefType "journal-article" @default.
• W1724049693 hasAuthorship W1724049693A5006543842 @default.
• W1724049693 hasAuthorship W1724049693A5008812852 @default.
• W1724049693 hasAuthorship W1724049693A5025840041 @default.
• W1724049693 hasAuthorship W1724049693A5043176593 @default.
• W1724049693 hasAuthorship W1724049693A5053521833 @default.
• W1724049693 hasAuthorship W1724049693A5088893766 @default.
• W1724049693 hasBestOaLocation W17240496931 @default.
• W1724049693 hasConcept C126322002 @default.
• W1724049693 hasConcept C143998085 @default.
• W1724049693 hasConcept C207103383 @default.
• W1724049693 hasConcept C2776256026 @default.
• W1724049693 hasConcept C2776694085 @default.
• W1724049693 hasConcept C2778239845 @default.
• W1724049693 hasConcept C2780258809 @default.
• W1724049693 hasConcept C2781190966 @default.
• W1724049693 hasConcept C2781451048 @default.
• W1724049693 hasConcept C44249647 @default.
• W1724049693 hasConcept C71924100 @default.
• W1724049693 hasConceptScore W1724049693C126322002 @default.
• W1724049693 hasConceptScore W1724049693C143998085 @default.
• W1724049693 hasConceptScore W1724049693C207103383 @default.
• W1724049693 hasConceptScore W1724049693C2776256026 @default.
• W1724049693 hasConceptScore W1724049693C2776694085 @default.
• W1724049693 hasConceptScore W1724049693C2778239845 @default.
• W1724049693 hasConceptScore W1724049693C2780258809 @default.
• W1724049693 hasConceptScore W1724049693C2781190966 @default.
• W1724049693 hasConceptScore W1724049693C2781451048 @default.

• next